Cryptococcus neoformans Dual GDP-mannose transporters and their role in biology and virulence

Eukaryotic Cell

Volumn 13, Issue 6, 2014, Pages 832-842

  Wang, Zhuo A ^a   Griffith, Cara L ^a,c   Skowyra, Michael L ^a   Salinas, Nichole ^a   Williams, Matthew ^a   Maier, Ezekiel J ^a,b   Gish, Stacey R ^a   Liu, Hong ^a,c   Brent, Michael R ^a,b   Doering, Tamara L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c MONSANTO COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; FUNGAL PROTEIN; GDP-MANNOSE TRANSPORTER;

ANIMAL; CRYPTOCOCCUS NEOFORMANS; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MOUSE; PATHOGENICITY; VIRULENCE;

ANIMALS; CARRIER PROTEINS; CRYPTOCOCCUS NEOFORMANS; FUNGAL PROTEINS; MICE; VIRULENCE;

EID: 84901420428     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.00054-14     Document Type: Article

References (62)

1. Lowe JB, Marth JD. 2003. A genetic approach to mammalian glycan function. Annu. Rev. Biochem. 72: 643-691. http://dx.doi.org/10.1146/annurev.biochem.72.121801.161809.
2. Gemmill TR, Trimble RB. 1999. Overview of N-and O-linked oligosaccharide structures found in various yeast species. Biochim. Biophys. Acta 1426: 227-237. http://dx.doi.org/10.1016/S0304-4165(98)00126-3.
3. Park JN, Lee DJ, Kwon O, Oh DB, Bahn YS, Kang HA. 2012. Unraveling unique structure and biosynthesis pathway of N-linked glycans in human fungal pathogen Cryptococcus neoformans by glycomics analysis. J. Biol. Chem. 287: 19501-19515. http://dx.doi.org/10.1074/jbc.M112.354209.
4. Reilly MC, Aoki K, Wang ZA, Skowyra ML, Williams M, Tiemeyer M, Doering TL. 2011. A xylosylphosphotransferase of Cryptococcus neoformans acts in protein O-glycan synthesis. J. Biol. Chem. 286: 26888-26899. http://dx.doi.org/10.1074/jbc.M111.262162.
5. Klis FM, Boorsma A, De Groot PW. 2006. Cell wall construction in Saccharomyces cerevisiae. Yeast 23: 185-202. http://dx.doi.org/10.1002/yea.1349.
6. Orlean P, Menon AK. 2007. Thematic review series: lipid posttranslational modifications. GPI anchoring of protein in yeast and mammalian cells, or: how we learned to stop worrying and love glycophospholipids. J. Lipid Res. 48: 993-1011. http://dx.doi.org/10.1194/jlr.R700002-JLR200.
7. Freeze HH, Elbein AD. 2009. Glycosylation precursors, chapter 4, p 47-61. In Varki A, Cummings RD, Esko JD, Freeze H, Stanley P, Bertozzi CR, Hart GW, Etzler ME (ed), Essentials of glycobiology, 2nd ed. Cold Spring Harbor Press, Cold Spring Harbor, NY.
8. Helenius J, Aebi M. 2002. Transmembrane movement of dolichol linked carbohydrates during N-glycoprotein biosynthesis in the endoplasmic reticulum. Semin. Cell Dev. Biol. 13: 171-178. http://dx.doi.org/10.1016/S1084-9521(02)00045-9.
9. Liu L, Xu YX, Hirschberg CB. 2010. The role of nucleotide sugar transporters in development of eukaryotes. Semin. Cell Dev. Biol. 21: 600-608. http://dx.doi.org/10.1016/j.semcdb.2010.02.002.
10. Gerardy-Schahn R, Oelmann S, Bakker H. 2001. Nucleotide sugar transporters: biological and functional aspects. Biochimie 83: 775-782. http://dx.doi.org/10.1016/S0300-9084(01)01322-0.
11. Abeijon C, Orlean P, Robbins PW, Hirschberg CB. 1989. Topography of glycosylation in yeast: characterization of GDPmannose transport and lumenal guanosine diphosphatase activities in Golgi-like vesicles. Proc. Natl. Acad. Sci. U. S. A. 86: 6935-6939. http://dx.doi.org/10.1073/pnas.86.18.6935.
12. Poster JB, Dean N. 1996. The yeast VRG4 gene is required for normal Golgi functions and defines a new family of related genes. J. Biol. Chem. 271: 3837-3845. http://dx.doi.org/10.1074/jbc.271.7.3837.
13. Dean N, Zhang YB, Poster JB. 1997. The VRG4 gene is required for GDP-mannose transport into the lumen of the Golgi in the yeast, Saccharomyces cerevisiae. J. Biol. Chem. 272: 31908-31914. http://dx.doi.org/10.1074/jbc.272.50.31908.
14. Baldwin TC, Handford MG, Yuseff MI, Orellana A, Dupree P. 2001. Identification and characterization of GONST1, a Golgi-localized GDPmannose transporter in Arabidopsis. Plant Cell 13: 2283-2295. http://dx.doi.org/10.1105/tpc.13.10.2283, http://dx.doi.org/10.2307/3871508.
15. Ueki N, Nishii I. 2009. Controlled enlargement of the glycoprotein vesicle surrounding a volvox embryo requires the InvB nucleotide-sugar transporter and is required for normal morphogenesis. Plant Cell 21: 1166-1181. http://dx.doi.org/10.1105/tpc.109.066159.
16. Handford MG, Sicilia F, Brandizzi F, Chung JH, Dupree P. 2004. Arabidopsis thaliana expresses multiple Golgi-localised nucleotide-sugar transporters related to GONST1. Mol. Genet. Genomics 272: 397-410. http://dx.doi.org/10.1007/s00438-004-1071-z.
17. Ma D, Russell DG, Beverley SM, Turco SJ. 1997. Golgi GDP-mannose uptake requires Leishmania LPG2. A member of a eukaryotic family of putative nucleotide-sugar transporters. J. Biol. Chem. 272: 3799-3805.
18. Descoteaux A, Luo Y, Turco SJ, Beverley SM. 1995. A specialized pathway affecting virulence glycoconjugates of Leishmania. Science 269: 1869-1872. http://dx.doi.org/10.1126/science.7569927.
19. Ballou L, Hitzeman RA, Lewis MS, Ballou CE. 1991. Vanadate-resistant yeast mutants are defective in protein glycosylation. Proc. Natl. Acad. Sci. U. S. A. 88: 3209-3212. http://dx.doi.org/10.1073/pnas.88.8.3209.
20. Arakawa K, Abe M, Noda Y, Adachi H, Yoda K. 2006. Molecular cloning and characterization of a Pichia pastoris ortholog of the yeast Golgi GDPmannose transporter gene. J. Gen. Appl. Microbiol. 52: 137-145. http://dx.doi.org/10.2323/jgam.52.137.
21. Carvalho ND, Arentshorst M, Weenink XO, Punt PJ, van den Hondel CA, Ram AF. 2011. Functional YFP-tagging of the essential GDPmannose transporter reveals an important role for the secretion related small GTPase SrgC protein in maintenance of Golgi bodies in Aspergillus niger. Fungal Biol. 115: 253-264. http://dx.doi.org/10.1016/j.funbio.2010.12.010.
22. Engel J, Schmalhorst PS, Routier FH. 2012. Biosynthesis of the fungal cell wall polysaccharide galactomannan requires intraluminal GDP-mannose. J. Biol. Chem. 287: 44418-44424. http://dx.doi.org/10.1074/jbc.M112.398321.
23. Nishikawa A, Mendez B, Jigami Y, Dean N. 2002. Identification of a Candida glabrata homologue of the S. cerevisiae VRG4 gene, encoding the Golgi GDP-mannose transporter. Yeast 19: 691-698. http://dx.doi.org/10.1002/yea.854.
24. Nishikawa A, Poster JB, Jigami Y, Dean N. 2002. Molecular and phenotypic analysis of CaVRG4, encoding an essential Golgi apparatus GDPmannose transporter. J. Bacteriol. 184: 29-42. http://dx.doi.org/10.1128/JB.184.1.29-42.2002.
25. Jackson-Hayes L, Hill TW, Loprete DM, Fay LM, Gordon BS, Nkashama SA, Patel RK, Sartain CV. 2008. Two GDP-mannose transporters contribute to hyphal form and cell wall integrity in Aspergillus nidulans. Microbiology 154: 2037-2047. http://dx.doi.org/10.1099/mic.0.2008/017483-0.
26. Jackson-Hayes L, Hill TW, Loprete DM, Gordon BS, Groover CJ, Johnson LR, Martin SA. 2010. GDP-mannose transporter paralogues play distinct roles in polarized growth of Aspergillus nidulans. Mycologia 102: 305-310. http://dx.doi.org/10.3852/09-138.
27. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. 2009. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23: 525-530. http://dx.doi.org/10.1097/QAD.0b013e328322ffac.
28. Doering TL. 2009. How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans. Annu. Rev. Microbiol. 63: 223-247. http://dx.doi.org/10.1146/annurev.micro.62.081307.162753.
29. Heise N, Gutierrez AL, Mattos KA, Jones C, Wait R, Previato JO, Mendonca-Previato L. 2002. Molecular analysis of a novel family of complex glycoinositolphosphoryl ceramides from Cryptococcus neoformans: structural differences between encapsulated and acapsular yeast forms. Glycobiology 12: 409-420. http://dx.doi.org/10.1093/glycob/cwf053.
30. Olson GM, Fox DS, Wang P, Alspaugh JA, Buchanan KL. 2007. Role of protein O-mannosyltransferase Pmt4 in the morphogenesis and virulence of Cryptococcus neoformans. Eukaryot. Cell 6: 222-234. http://dx.doi.org/10.1128/EC.00182-06.
31. Kumar P, Yang M, Haynes BC, Skowyra ML, Doering TL. 2011. Emerging themes in cryptococcal capsule synthesis. Curr. Opin. Struct. Biol. 21: 597-602. http://dx.doi.org/10.1016/j.sbi.2011.08.006.
32. 1Hnuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network. Clin. Diagn. Lab. Immunol. 5: 146-159.
33. Chang YC, Kwon-Chung KJ. 1994. Complementation of a capsuledeficient mutation of Cryptococcus neoformans restores its virulence. Mol. Cell. Biol. 14: 4912-4919.
34. Yoneda A, Doering TL. 2006. A eukaryotic capsular polysaccharide is synthesized intracellularly and secreted via exocytosis. Mol. Biol. Cell 17: 5131-5140. http://dx.doi.org/10.1091/mbc.E06-08-0701.
35. Zaragoza O, Rodrigues ML, De Jesus M, Frases S, Dadachova E, Casadevall A. 2009. The capsule of the fungal pathogen Cryptococcus neoformans. Adv. Appl. Microbiol. 68: 133-216. http://dx.doi.org/10.1016/S0065-2164(09)01204-0.
36. Vaishnav VV, Bacon BE, O'Neill M, Cherniak R. 1998. Structural characterization of the galactoxylomannan of Cryptococcus neoformans Cap67. Carbohydr. Res. 306: 315-330.
37. Heiss C, Klutts JS, Wang Z, Doering TL, Azadi P. 2009. The structure of Cryptococcus neoformans galactoxylomannan contains beta-D-glucuronic acid. Carbohydr. Res. 344: 915-920.
38. Heiss C, Skowyra ML, Liu H, Klutts JS, Wang Z, Williams M, Srikanta D, Beverley SM, Azadi P, Doering TL. 2013. Unusual galactofuranose modification of a capsule polysaccharide in the pathogenic yeast Cryptococcus neoformans. J. Biol. Chem. 288: 10994-1003. http://dx.doi.org/10.1074/jbc.M112.441998.
39. Cottrell TR, Griffith CL, Liu H, Nenninger AA, Doering TL. 2007. The pathogenic fungus Cryptococcus neoformans expresses two functional GDP-mannose transporters with distinct expression patterns and roles in capsule synthesis. Eukaryot. Cell 6: 776-785. http://dx.doi.org/10.1128/EC.00015-07.
40. Hua J, Meyer JD, Lodge JK. 2000. Development of positive selectable markers for the fungal pathogen Cryptococcus neoformans. Clin. Diagn. Lab. Immunol. 7: 125-128.
41. Reilly MC, Levery SB, Castle SA, Klutts JS, Doering TL. 2009. A novel xylosylphosphotransferase activity discovered in Cryptococcus neoformans. J. Biol. Chem. 284: 36118-36127. http://dx.doi.org/10.1074/jbc.M109.056226.
42. Fu J, Hettler E, Wickes BL. 2006. Split marker transformation increases homologous integration frequency in Cryptococcus neoformans. Fungal Genet. Biol. 43: 200-212. http://dx.doi.org/10.1016/j.fgb.2005.09.007.
43. McDade HC, Cox GM. 2001. A new dominant selectable marker for use in Cryptococcus neoformans. Med. Mycol. 39: 151-154. http://dx.doi.org/10.1080/mmy.39.1.151.154.
44. Bose I, Doering TL. 2011. Efficient implementation of RNA interference in the pathogenic yeast Cryptococcus neoformans. J. Microbiol. Methods 86: 156-159. http://dx.doi.org/10.1016/j.mimet.2011.04.014.
45. Franzusoff A, Schekman R. 1989. Functional compartments of the yeast Golgi apparatus are defined by the sec7 mutation. EMBO J. 8: 2695-2702.
46. Kuehn MJ, Schekman R, Ljungdahl PO. 1996. Amino acid permeases require COPII components and the ER resident membrane protein Shr3p for packaging into transport vesicles in vitro. J. Cell Biol. 135: 585-595.
47. Haynes BC, Skowyra ML, Spencer SJ, Gish SR, Williams M, Held EP, Brent MR, Doering TL. 2011. Toward an integrated model of capsule regulation in Cryptococcus neoformans. PLoS Pathog. 7: e1002411. http://dx.doi.org/10.1371/journal.ppat.1002411.
48. Griffith CL, Klutts JS, Zhang L, Levery SB, Doering TL. 2004. UDPglucose dehydrogenase plays multiple roles in the biology of the pathogenic fungus Cryptococcus neoformans. J. Biol. Chem. 279: 51669-51676. http://dx.doi.org/10.1074/jbc.M408889200.
49. Wills EA, Roberts IS, Del Poeta M, Rivera J, Casadevall A, Cox GM, Perfect JR. 2001. Identification and characterization of the Cryptococcus neoformans phosphomannose isomerase-encoding gene, MAN1, and its impact on pathogenicity. Mol. Microbiol. 40: 610-620. http://dx.doi.org/10.1046/j.1365-2958.2001.02401.x.
50. Yoneda A, Doering TL. 2008. Regulation of Cryptococcus neoformans capsule size is mediated at the polymer level. Eukaryot. Cell 7: 546-549. http://dx.doi.org/10.1128/EC.00437-07.
51. Frases S, Pontes B, Nimrichter L, Viana NB, Rodrigues ML, Casadevall A. 2009. Capsule of Cryptococcus neoformans grows by enlargement of polysaccharide molecules. Proc. Natl. Acad. Sci. U. S. A. 106: 1228-1233. http://dx.doi.org/10.1073/pnas.0808995106.
52. Puthenveedu MA, Linstedt AD. 2005. Subcompartmentalizing the Golgi apparatus. Curr. Opin. Cell Biol. 17: 369-375. http://dx.doi.org/10.1016/j.ceb.2005.06.006.
53. Sprong H, Degroote S, Nilsson T, Kawakita M, Ishida N, van der Sluijs P, van Meer G. 2003. Association of the Golgi UDP-galactose transporter with UDP-galactose:ceramide galactosyltransferase allows UDP-galactose import in the endoplasmic reticulum. Mol. Biol. Cell 14: 3482-3493. http://dx.doi.org/10.1091/mbc.E03-03-0130.
54. Kotz A, Wagener J, Engel J, Routier FH, Echtenacher B, Jacobsen I, Heesemann J, Ebel F. 2010. Approaching the secrets of N-glycosylation in Aspergillus fumigatus: characterization of the AfOch1 protein. PLoS One 5: e15729. http://dx.doi.org/10.1371/journal.pone.0015729.
55. Yamamoto-Hino M, Abe M, Shibano T, Setoguchi Y, Awano W, Ueda R, Okano H, Goto S. 2012. Cisterna-specific localization of glycosylationrelated proteins to the Golgi apparatus. Cell Struct. Funct 37: 55-63. http://dx.doi.org/10.1247/csf.11037.
56. Schoberer J, Strasser R. 2011. Sub-compartmental organization of Golgiresident N-glycan processing enzymes in plants. Mol. Plant 4: 220-228. http://dx.doi.org/10.1093/mp/ssq082.
57. Kamiyama D, Huang B. 2012. Development in the STORM. Dev. Cell 23: 1103-1110. http://dx.doi.org/10.1016/j.devcel.2012.10.003.
58. Abe M, Hashimoto H, Yoda K. 1999. Molecular characterization of Vig4/Vrg4 GDP-mannose transporter of the yeast Saccharomyces cerevisiae. FEBS Lett. 458: 309-312.
59. Gao XD, Dean N. 2000. Distinct protein domains of the yeast Golgi GDP-mannose transporter mediate oligomer assembly and export from the endoplasmic reticulum. J. Biol. Chem. 275: 17718-17727. http://dx.doi.org/10.1074/jbc.M909946199.
60. Hong K, Ma D, Beverley SM, Turco SJ. 2000. The Leishmania GDPmannose transporter is an autonomous, multi-specific, hexameric complex of LPG2 subunits. Biochemistry 39: 2013-2022. http://dx.doi.org/10.1021/bi992363l.
61. Nielsen K, Cox GM, Wang P, Toffaletti DL, Perfect JR, Heitman J. 2003. Sexual cycle of Cryptococcus neoformans var. grubii and virulence of congenic a and alpha isolates. Infect. Immun. 71: 4831-4841. http://dx.doi.org/10.1128/IAI.71.9.4831-4841.2003.
62. Kwon-Chung KJ, Wickes BL, Stockman L, Roberts GD, Ellis D, Howard DH. 1992. Virulence, serotype, and molecular characteristics of environmental strains of Cryptococcus neoformans var. gattii. Infect. Immun. 60: 1869-1874.